A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in individuals injecting substances of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Elimination
Based on TikTok, the platform has removed problematic content and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of weight loss, positive reviews and detailed guides for preparing or administering at residence.
After minutes of joining one community, a seller posted contact information, where most transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Details and Costs
Within these communities, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how long a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly serious health risks”.
